{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:35:57Z","timestamp":1793147757577,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kainos Medicine, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41397-026-00431-3","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:48:41Z","timestamp":1790596121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of drug-induced liver injury in multiple system atrophy patients treated with KM-819 is potentially associated with the HLA-DPB1*05:01:01:01 allele"],"prefix":"10.1038","volume":"26","author":[{"given":"Jeong-Hoon","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar Stef\u00e1n","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Hendricks","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-4896","authenticated-orcid":false,"given":"M. Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2029-9985","authenticated-orcid":false,"given":"Suyoung","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Stankeviciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-4830","authenticated-orcid":false,"given":"Guruprasad P.","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyuchan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrolee","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9720-236X","authenticated-orcid":false,"given":"Eunhee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"431_CR1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001371RR","volume":"35","author":"BS Kim","year":"2021","unstructured":"Kim BS, Jang T, Yoo SE, Lee JM, Kim E. Fas-associated factor 1 induces the accumulation of \u03b1-synuclein through autophagic suppression in dopaminergic neurons. FASEB J. 2021;35:e21363.","journal-title":"FASEB J"},{"key":"431_CR2","doi-asserted-by":"publisher","first-page":"24003","DOI":"10.1074\/jbc.M302200200","volume":"278","author":"SW Ryu","year":"2003","unstructured":"Ryu SW, Lee SJ, Park MY, Jun JI, Jung YK, Kim E. Fas-associated factor 1, FAF1, is a member of Fas death-inducing signaling complex. J Biol Chem. 2003;278:24003\u201310.","journal-title":"J Biol Chem"},{"key":"431_CR3","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/cdd.2016.99","volume":"23","author":"C Yu","year":"2016","unstructured":"Yu C, Kim BS, Kim E. FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration. Cell Death Differ. 2016;23:1873\u201385.","journal-title":"Cell Death Differ"},{"key":"431_CR4","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s13311-020-00890-x","volume":"17","author":"MR Burns","year":"2020","unstructured":"Burns MR, McFarland NR. Current management and emerging therapies in multiple system atrophy. Neurotherapeutics. 2020;17:1582\u2013602.","journal-title":"Neurotherapeutics"},{"key":"431_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231163410","volume":"16","author":"T Hosack","year":"2023","unstructured":"Hosack T, Damry D, Biswas S. Drug-induced liver injury: a comprehensive review. Ther Adv Gastroenterol. 2023;16:17562848231163410.","journal-title":"Ther Adv Gastroenterol"},{"key":"431_CR6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1007\/s40264-014-0185-4","volume":"37","author":"A Regev","year":"2014","unstructured":"Regev A, Seeff LB, Merz M, Ormarsdottir S, Aithal GP, Gallivan J, et al. Causality assessment for suspected DILI during clinical phases of drug development. Drug Saf. 2014;37:S47\u201356.","journal-title":"Drug Saf"},{"key":"431_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806\u201315.","journal-title":"Clin Pharmacol Ther"},{"key":"431_CR8","doi-asserted-by":"publisher","first-page":"e113501","DOI":"10.1371\/journal.pone.0113501","volume":"9","author":"J Rhodes","year":"2014","unstructured":"Rhodes J, Beale MA, Fisher MC. Illuminating choices for library prep: a comparison of library preparation methods for whole genome sequencing of Cryptococcus neoformans using Illumina HiSeq. PLoS One. 2014;9:e113501.","journal-title":"PLoS One"},{"key":"431_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000502487","volume":"46","author":"S Klasberg","year":"2019","unstructured":"Klasberg S, Surendranath V, Lange V, Sch\u00f6fl G. bioinformatics strategies, challenges, and opportunities for next generation sequencing-based HLA genotyping. Transfus Med Hemother. 2019;46:312\u201325.","journal-title":"Transfus Med Hemother"},{"key":"431_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.821189","volume":"13","author":"L Marsili","year":"2022","unstructured":"Marsili L, Duque KR, Bode RL, Kauffman MA, Espay AJ. Uncovering essential tremor genetics: the promise of long-read sequencing. Front Neurol. 2022;13:821189.","journal-title":"Front Neurol"},{"key":"431_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-023-00522-3","volume":"17","author":"JB Oehler","year":"2023","unstructured":"Oehler JB, Wright H, Stark Z, Mallett AJ, Schmitz U. The application of long-read sequencing in clinical settings. Hum Genomics. 2023;17:73.","journal-title":"Hum Genomics"},{"key":"431_CR12","unstructured":"NCBI GRCh38. p14 human reference genome. https:\/\/www.ncbi.nlm.nih.gov\/datasets\/genome\/GCF_000001405.40\/."},{"key":"431_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"431_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"Cingolani","year":"2012","unstructured":"Cingolani, Platts P, Wang A, lL, Coon M, Nguyen T, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. 2012;6:80\u201392.","journal-title":"Fly"},{"key":"431_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"431_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404\u201313.","journal-title":"Biometrika"},{"key":"431_CR17","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/sim.2677","volume":"26","author":"ND Mercaldo","year":"2007","unstructured":"Mercaldo ND, Lau KF, Zhou XH. Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. 2007;26:2170\u201383.","journal-title":"Stat Med"},{"key":"431_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4097\/kja.19049","volume":"72","author":"CY Lim","year":"2019","unstructured":"Lim CY, In J. Randomization in clinical studies. Korean J Anesthesiol. 2019;72:221\u201332.","journal-title":"Korean J Anesthesiol"},{"key":"431_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cpt.2350","volume":"110","author":"M Whirl-Carrillo","year":"2021","unstructured":"Whirl-Carrillo M, Huddart R, Gong L, Sangkuhl K, Thorn CF, Whaley R, et al. An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2021;110:563\u201372.","journal-title":"Clin Pharmacol Ther"},{"key":"431_CR20","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.3390\/jcm13123563","volume":"13","author":"B Kim","year":"2024","unstructured":"Kim B, Kim J, Yoon S-Y, Cheong HS, Kwon M-J, Yeom J-S, et al. HLA-DPB1* 05: 01 and HLA-A* 11: 01 is associated with adverse drug reactions to isoniazid and rifampin for treatment of latent tuberculosis infection in South Korea. J Clin Med. 2024;13:3563.","journal-title":"J Clin Med"},{"key":"431_CR21","doi-asserted-by":"publisher","unstructured":"A collection of immune related gene-lists from ImmPort. 2024. https:\/\/doi.org\/10.21430\/9PD6-Z002.","DOI":"10.21430\/9PD6-Z002"},{"key":"431_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41439-022-00226-5","volume":"9","author":"JK Kulski","year":"2022","unstructured":"Kulski JK, Suzuki S, Shiina T. Human leukocyte antigen super-locus: nexus of genomic supergenes, SNPs, indels, transcripts, and haplotypes. Hum Genome Var. 2022;9:49.","journal-title":"Hum Genome Var"},{"key":"431_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9710376","volume":"2022","author":"S Medhasi","year":"2022","unstructured":"Medhasi S, Chantratita N. Human leukocyte antigen (HLA) system: genetics and association with bacterial and viral infections. J Immunol Res. 2022;2022:9710376.","journal-title":"J Immunol Res"},{"key":"431_CR24","volume":"103","author":"J Robinson","year":"2024","unstructured":"Robinson J, Barker DJ, Marsh SGE. 25\u2009years of the IPD-IMGT\/. HLA Database HLA. 2024;103:e15549.","journal-title":"HLA Database HLA"},{"key":"431_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-1-8","volume":"1","author":"P Jin","year":"2003","unstructured":"Jin P, Wang E. Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling. J Transl Med. 2003;1:8.","journal-title":"J Transl Med"},{"key":"431_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00251-012-0615-3","volume":"64","author":"JA Hollenbach","year":"2012","unstructured":"Hollenbach JA, Madbouly A, Gragert L, Vierra-Green C, Flesch S, Spellman S, et al. A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. Immunogenetics. 2012;64:559\u201369.","journal-title":"Immunogenetics"},{"key":"431_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1034\/j.1399-0039.2001.057005424.x","volume":"57","author":"AB Begovich","year":"2001","unstructured":"Begovich AB, Moonsamy PV, Mack SJ, Barcellos LF, Steiner LL, Grams S, et al. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens. 2001;57:424\u201339.","journal-title":"Tissue Antigens"},{"key":"431_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMoa0706135","volume":"358","author":"S Mallal","year":"2008","unstructured":"Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358:568\u201379.","journal-title":"N Engl J Med"},{"key":"431_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428:486.","journal-title":"Nature"},{"key":"431_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ph15010004","volume":"15","author":"LEN Manson","year":"2021","unstructured":"Manson LEN, van den Hout WB, Guchelaar HJ. Genotyping for HLA risk alleles to prevent drug hypersensitivity reactions: impact analysis. Pharmaceuticals. 2021;15:4.","journal-title":"Pharmaceuticals"},{"key":"431_CR31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/clpt.2011.355","volume":"91","author":"MA Martin","year":"2012","unstructured":"Martin MA, Klein TE, Dong BJ, Pirmohamed M, Haas DW, Kroetz DL, et al. Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing. Clin Pharmacol Ther. 2012;91:734\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"431_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1651-2227.2006.00180.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng AK. Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta paediatrica. 2007;96:338\u201341.","journal-title":"Acta paediatrica"},{"key":"431_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/tan.14980","volume":"101","author":"K Jung","year":"2023","unstructured":"Jung K, Kim JG, Shin S, Roh EY, Hong YJ, Song EY. Allele and haplotype frequencies of 11 HLA loci in Koreans by next-generation sequencing. HLA. 2023;101:602\u201312.","journal-title":"HLA"},{"key":"431_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-11-724","volume":"11","author":"RC Johnson","year":"2010","unstructured":"Johnson RC, Nelson GW, Troyer JL, Lautenberger JA, Kessing BD, Winkler CA, et al. Accounting for multiple comparisons in a genome-wide association study (GWAS). BMC Genomics. 2010;11:724.","journal-title":"BMC Genomics"},{"key":"431_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/tpj.2008.4","volume":"9","author":"MR Nelson","year":"2009","unstructured":"Nelson MR, Bacanu SA, Mosteller M, Li L, Bowman CE, Roses AD, et al. Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions. Pharmacogenomics J. 2009;9:23\u201333.","journal-title":"Pharmacogenomics J"},{"key":"431_CR36","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza FF, McCabe A, Santos EJMD, Jones J, Takeshita L, Ortega-Rivera ND, et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 2020;48:D783\u2013D8. D1","journal-title":"Nucleic Acids Res"},{"key":"431_CR37","unstructured":"Du Z, Patel J, Braun C, Norton B, editors. HLA-DPA1 and HLA-DPB1 frequencies in the US populations. AMERICAN JOURNAL OF TRANSPLANTATION; 2017: WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA."},{"key":"431_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cpt.1375","volume":"106","author":"P Nicoletti","year":"2019","unstructured":"Nicoletti P, Aithal GP, Chamberlain TC, Coulthard S, Alshabeeb M, Grove JI, et al. Drug-Induced liver injury due to flucloxacillin: relevance of multiple human leukocyte antigen alleles. Clin Pharmacol Ther. 2019;106:245\u201353.","journal-title":"Clin Pharmacol Ther"},{"key":"431_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41397-020-0159-0","volume":"20","author":"CD Bruno","year":"2020","unstructured":"Bruno CD, Fremd B, Church RJ, Daly AK, Aithal GP, Bj\u00f6rnsson ES, et al. HLA associations with infliximab-induced liver injury. Pharmacogenomics J. 2020;20:681\u20136.","journal-title":"Pharmacogenomics J"},{"key":"431_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00251-021-01213-w","volume":"73","author":"G Ou","year":"2021","unstructured":"Ou G, Liu X, Xu H, Ji X, Wang J. Variation and expression of HLA-DPB1 gene in HBV infection. Immunogenetics. 2021;73:253\u201361.","journal-title":"Immunogenetics"},{"key":"431_CR41","doi-asserted-by":"publisher","first-page":"e53910","DOI":"10.1371\/journal.pone.0053910","volume":"8","author":"H Furukawa","year":"2013","unstructured":"Furukawa H, Oka S, Shimada K, Sugii S, Hashimoto A, Komiya A, et al. Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro\/SS-A and anti-La\/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients. PLoS One. 2013;8:e53910.","journal-title":"PLoS One"},{"key":"431_CR42","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/molecules29051004","volume":"29","author":"HI Choi","year":"2024","unstructured":"Choi HI, Kim T, Kim JW, Lee GJ, Choi J, Chae YJ, et al. Rat pharmacokinetics and in vitro metabolite identification of KM-819, a parkinson\u2019s disease candidate, using LC-MS\/MS and LC-HRMS. Molecules. 2024;29:1004.","journal-title":"Molecules"},{"key":"431_CR43","doi-asserted-by":"publisher","first-page":"e0253619","DOI":"10.1371\/journal.pone.0253619","volume":"16","author":"IC Baek","year":"2021","unstructured":"Baek IC, Choi EJ, Shin DH, Kim HJ, Choi H, Kim TG. Allele and haplotype frequencies of human leukocyte antigen-A, -B, -C, -DRB1, -DRB3\/4\/5, -DQA1, -DQB1, -DPA1, and -DPB1 by next generation sequencing-based typing in Koreans in South Korea. PLoS One. 2021;16:e0253619.","journal-title":"PLoS One"},{"key":"431_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100.","journal-title":"Nature"},{"key":"431_CR45","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","volume":"53","author":"U Consortium","year":"2025","unstructured":"Consortium U. UniProt: the universal protein knowledgebase in 2025. Nucleic Acids Res. 2025;53:D609\u2013D17.","journal-title":"Nucleic Acids Res"},{"key":"431_CR46","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1096\/fj.09-133082","volume":"24","author":"YY Xie","year":"2010","unstructured":"Xie YY, Zhou CJ, Zhou ZR, Hong J, Che MX, Fu QS, et al. Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication. FASEB J. 2010;24:196\u2013205.","journal-title":"FASEB J"},{"key":"431_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1067234","volume":"13","author":"G You","year":"2023","unstructured":"You G, Zhou C, Wang L, Liu Z, Fang H, Yao X, et al. COMMD proteins function and their regulating roles in tumors. Front Oncol. 2023;13:1067234.","journal-title":"Front Oncol"},{"key":"431_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.53388\/2022020206","volume":"4","author":"X Duan","year":"2022","unstructured":"Duan X, Li S, Wang Q. Prediction of the mechanisms of liver injury of epimedii folium by network pharmacology and validation in HepaRG Cells. Toxicol Commun. 2022;4:6.","journal-title":"Toxicol Commun"},{"key":"431_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01421-5","volume":"16","author":"RK Hart","year":"2024","unstructured":"Hart RK, Fokkema IFAC, DiStefano M, Hastings R, Laros JFJ, Taylor R, et al. HGVS Nomenclature 2024: improvements to community engagement, usability, and computability. Genome Med. 2024;16:149.","journal-title":"Genome Med"},{"key":"431_CR50","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2337\/db15-1115","volume":"65","author":"LP Zhao","year":"2016","unstructured":"Zhao LP, Alshiekh S, Zhao M, Carlsson A, Larsson HE, Forsander G, et al. Next-Generation sequencing reveals that HLA-DRB3, -DRB4, and -DRB5 may be associated with islet autoantibodies and risk for childhood type 1 diabetes. Diabetes. 2016;65:710\u20138.","journal-title":"Diabetes"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00431-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00431-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00431-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:21:59Z","timestamp":1793146919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00431-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1038\/s41397-026-00431-3","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jeong-Hoon Han, Suyoung Go, Kyuchan Kim, Carrolee Barlow, and Eunhee Kim are employees of Kainos Medicine, Inc., the company developing KM-819. Simona Stankeviciute is an employee of Parexel, a contract research organization. Ra\u00fal J. Andrade, Einar Stef\u00e1n Bj\u00f6rnsson, James Hendricks Lewis, M Isabel Lucena, Guruprasad P. Aithal, and Chong Sik Lee declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All procedures were performed in accordance with the principles of the Declaration of Helsinki and relevant guidelines and regulations. This study was approved by the IRB of CHA Bundang Medical Center, CHA University (IRB No. 2025-02-061-005). Informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"37"}}